An international team led by investigators at Pfizer Oncology, BGI-Shenzhen, the University of Copenhagen, and Eli Lilly and Company used whole-genome sequencing to track down recurrent genetic glitches in the liver cancer hepatocellular carcinoma — particularly forms of the disease involving hepatitis B virus infection.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in PLOS

This Week in PNAS

This Week in PNAS

This Week in PLOS

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.